TACE联合射频消融治疗原发性肝癌患者疗效研究  

Efficacy of TACE and radiofrequency ablation combination in the treatment of patients with primary liver cancer

作　　者：乔敏 赵一鉴[2] 张建巧 景赟杭[3] Qiao Min;Zhao Yijian;Z hang Jianqiao(Department of Radiology,Central Hospital,Shangluo 726000,Shaanxi Province,China)

机构地区：[1]陕西省商洛市中心医院CT室,726000 [2]陕西省商洛市中心医院肿瘤内科,726000 [3]延安大学附属医院CT诊断科

出　　处：《实用肝脏病杂志》2021年第1期119-122,共4页Journal of Practical Hepatology

基　　金：陕西省社会发展科技攻关项目(编号:2010K16-01-09)。

摘　　要：目的观察采用肝动脉化疗栓塞(TACE)联合射频消融(RFA)治疗原发性肝癌(PLC)患者的疗效。方法2016年3月~2018年3月我院收治的PLC患者108例,采用随机数字表法将患者分为联合组和TACE组,每组54例。两组患者均接受TACE治疗,其中54例在TACE治疗的基础上联合RFA治疗。随访观察临床疗效和生存率。结果联合组有效率为77.8%,疾病控制率为87.0%,显著高于TACE组的50.0%和70.4%(P<0.05);治疗后,联合组血清总胆红素和甲胎蛋白水平分别为(24.0±6.7)μmol/L和(135.7±15.6)μg/L,显著低于TACE治疗组[分别为(28.3±8.2)μmol/L和(226.5±18.2)μg/L,P<0.05];在治疗期间,联合组不良反应发生率为48.2%,与TACE组的51.9%比,差异无统计学意义(P>0.05);联合组1 a生存率为75.0%(39/52),显著高于TACE组的47.2%(25/53),差异有统计学意义(χ^2=8.542,P=0.003)。结论采用TACE联合RFA治疗PLC患者安全有效,可提高近期生存率,值得进一步研究。Objective The aim of this study was to investigate the efficacy of transcatheter hepatic chemoembolization(TACE)and radiofrequency ablation(RFA)in treatment of patients with primary liver cancer(PLC).Methods A total of 108 patients with PLC were recruited in our hospital between March 2016 and March 2018,and were randomly divided into two groups,with 54 in each,receiving TACE or TACE and RFA combination.All patients were followed-up for 12 months.Results After treatment,the effective rate and disease control rate in patients receiving TACE and RFA were 77.8%and 87.0%,significantly higher than 50.0%and 70.4%(P<0.05)in TACE-treated group;one month after treatment,total serum bilirubin and alpha-fetoprotein levels in combination-treated group were(24.0±6.7)μmol/L and(135.7±15.6)μg/L,significantly lower than[(28.3±8.2)μmol/L and(226.5±18.2)μg/L,respectively,P<0.05]in TACE-treated group;during the treatment,the incidence in TACE-and RFA-treated patients was 48.2%,not significantly different compared to 51.9%in TACE-treated group(P>0.05);the one-year survival rate in TACE-and RFA-treated patients was 75.0%(39/52),significantly higher than,47.2%(25/53)in TACE-treated group(χ^2=8.542,P=0.003).Conclusion The application of TACE and RFA combination is safe and efficacious in the treatment of patients with PLC,which might prolong the survival of patients with PLC and warrants further investigation.

关 键 词：原发性肝癌 肝动脉化疗栓塞 射频消融 治疗 

分 类 号：R735.7[医药卫生—肿瘤]